# Human B-type Natriuretic Peptide (BNP) (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function

> **NCT00405639** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 37 (actual)

## Conditions studied

- Heart Failure
- Asymptomatic Systolic Dysfunction

## Interventions

- **DRUG:** Nesiritide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00405639
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2011-04
- **Final completion:** 2013-05
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2014-03-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00405639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00405639, "Human B-type Natriuretic Peptide (BNP) (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00405639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*